Published in Pharma Investments, Ventures and Law Weekly, September 24th, 2006
McDonnel, who was previously Corporate Controller, will take on additional responsibilities for financial reporting, Sarbanes-Oxley compliance and SEC reporting in his new position.
"Paul has proven himself to be an outstanding asset to the Arrowhead team," said R. Bruce Stewart, Arrowhead's chairman. "His operational experience has been invaluable to completing our SOX implementation, and his experience with acquisitions and due diligence will serve us well in the future."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.